Evaluating treatments for carbon monoxide poisoning in Korea
CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
This study is testing different treatments for people who have been poisoned by carbon monoxide to see how well they help with recovery and long-term health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Sex | All |
| Sponsor | Wonju Severance Christian Hospital Academic / other |
| Locations | 1 site (Wŏnju, Gangwon-do) |
| Trial ID | NCT04490317 on ClinicalTrials.gov |
What this trial studies
This prospective cohort study enrolls patients who have experienced carbon monoxide (CO) poisoning to assess the therapeutic effects of various treatments, including hyperbaric oxygen therapy and therapeutic hypothermia. The study aims to evaluate both short and long-term outcomes, such as neurocognitive effects and mortality rates, in these patients. Additionally, it investigates complications affecting the brain and heart due to CO exposure through imaging techniques and laboratory tests, while monitoring the patients' progress regularly by participating physicians.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have experienced acute carbon monoxide poisoning.
Not a fit: Patients who have declined to participate in the study will not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols and better outcomes for patients suffering from carbon monoxide poisoning.
How similar studies have performed: While there have been studies on carbon monoxide poisoning treatments, this specific approach evaluating multiple therapies and their outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute CO poisoning Exclusion Criteria: * Declined to enrollment in the study
Where this trial is running
Wŏnju, Gangwon-do
- Wonju Severance Christian Hospital — Wŏnju, Gangwon-do, South Korea (Recruiting)
Study contacts
- Principal investigator: Yong Sung Cha, MD — Wonju Severance Christian Hospital
- Study coordinator: Yong Sung Cha, MD
- Email: emyscha@yonsei.ac.kr
- Phone: +82-33-741-1615
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.